Clinical and pathogenetic justification of the use of the selective enterosorbent Alpesorb in acute intestinal infections with diarrheal syndrome | Ukrainian Medical Journal

Moroz L.V.,Androsova O.S.,Kulias S.M.,Popovych O.O.,Shmaliі V.I.,Kolesnyk O.M.,Kozlovskyi V.O.,Haletska V.H.

Main
Publications
Clinical and pathogenetic justification of the use of the selective enterosorbent Alpesorb in acute intestinal infections with diarrheal syndrome

Clinical and pathogenetic justification of the use of the selective enterosorbent Alpesorb in acute intestinal infections with diarrheal syndrome

May 29, 2026

297

УДК: 616.98:616.34+616.34-008.314.4+615.246.2

DOI: 10.32471/umj.1680-3051.277275

Keywords :

acute intestinal infections,

Alpesorb,

diarrhea,

diarrheal syndrome,

Polymethylsilylsesquioxane-Zincтм,

selective enterosorbent,

РSS-Znтм

Specialities :

Infectious diseases

Resume

A randomised controlled clinical trial was conducted to evaluate the use of the selective enterosorbent Alpesorb in patients with acute intestinal infections and diarrheal syndrome. It was found that the use of the selective enterosorbent Alpesorb in complex treatment, including antibiotics and rehydration preparations, significantly reduces the duration of diarrheal syndrome and improves clinical symptoms (reduces the intensity of clinical manifestations) compared to the control group.

References

1. Ali A.A., Naqvi S.K., Hasnain Z. et al. (2024) Zinc supplementation for acute and persistent watery diarrhoea in children: A systematic review and meta-analysis. J. Glob. Health, 14: 04212. DOI: 10.7189/jogh.14.04212.
2. Bajait C., Thawani V. (2011) Role of zinc in pediatric diarrhea. Indian. J. Pharmacol., 43(3): 232–235. DOI: 10.4103/0253-7613.81495.
3. Chiejina M., Samant H. (2026) Viral Diarrhea. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK470525.
4. World Health Organization (2004) Clinical management of acute diarrhoea: WHO/UNICEF joint statement. 8 p.
5. Dereje B., Yibabie S., Keno Z., Megersa A. (2023) Antibiotic utilization pattern in treatment of acute diarrheal diseases: the case of Hiwot Fana Specialized University Hospital, Harar, Ethiopia. J. Pharm. Policy Pract., 16(1): 62.
6. Dewidar H.I., Gomaa M., Abouzeid Y.A. et al. (2026) Distribution and Treatment of Infectious Diseases: Challenges for Developed and Developing Nations. Ch. 3. Antibacterial Therapy in Infectious Diseases, 31–58.
7. Diarrhoeal disease. http://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease.
8. Guarino A., Ashkenazi S., Gendrel D. et al. (2014) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition / European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J. Pediatr. Gastroenterol. Nutr., 59(1): 132–152. DOI: 10.1097/MPG.0000000000000375.
9. Howell C.A., Kemppinen A., Allgar V. et al. (2022) Double-blinded randomised placebo controlled trial of polymethylsiloxane polyhydrate for the treatment of IBS with diarrhoea (IBS-D). Gut, 71(12): 2430–2438. DOI: 10.1136/gutjnl-2022-327293.
10. Iqbal S., Malik Z.I., Al Dabbas M. et al. (2025) Zinc Fortification and Supplementation to Reduce Diarrhea in Children: A Literature Review. Diseases, 13(11): 380.
11. Jones R., Rubin G. (2009) Acute diarrhoea in adults. BMJ, 338: b1877.
12. Karnsakul W., Lifschitz C. (2003) Diarrheal (Diarrhoeal) diseases. Encyclopedia of Food Sciences and Nutrition, 18041813. DOI: 10.1016/B0-12-227055-X/00339-4.
13. Kim H.Y. (2017) Statistical notes for clinical researchers: Risk difference, risk ratio, and odds ratio. Restor Dent Endod., 42(1): 72–76. DOI: 10.5395/rde.2017.42.1.72.
14. Kolar M. (2022) Bacterial Infections, Antimicrobial Resistance and Antibiotic Therapy. Life (Basel), 12(4): 468. DOI: 10.3390/life12040468.
15. Lamberti L.M., Walker C.L., Chan K.Y. et al. (2013) Oral zinc supplementation for the treatment of acute diarrhea in children: a systematic review and meta-analysis. Nutrients, 5(11): 4715–4740. DOI: 10.3390/nu5114715.
16. Mishura A., Mazur D., Iaremov P. et al. (2026) Sorption Properties of Zinc-Containing Composite Sorbent — Innovative Composition of Polymethylsilsesquioxane-Zn™. EC Pharmacology and Toxicology, 14(1): 01–08.
17. Mulchandani R., Tiseo K., Nandi A. et al. (2025) Global trends in inappropriate use of antibiotics, 2000-2021: scoping review and prevalence estimates. BMJ Public Health, 3(1): e002411. DOI: 10.1136/bmjph-2024-002411.
18. Patel A., Mamtani M., Dibley M.J. et al. (2010) Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic review. PLoS One, 5(4): e10386.
19. Sistrom C.L., Garvan C.W. (2004) Proportions, odds, and risk. Radiology, 230(1): 12–19. DOI: 10.1148/radiol.2301031028.
20. Soloviev A., Kozlovskyi V., Ivanova I. et al. (2025) A New Sorbent Based on Polymethylsilsesquioxane-Zinc Effectively Inhibits the Contractile Activity of Guinea Pig Taenia coli. EC Pharmacology and Toxicology, 13(11): 01–07.
21. Troeger C., Blacker B.F., Khalil I.A. et al. (2018) Estimates of the Global, Regional, and National Morbidity, Mortality, and Aetiologies of Diarrhoea in 195 Countries: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases, 18: 1211–1228. DOI: doi.org/10.1016/S1473-3099(18)30362-1.
22. Garmanchuk L., Kozlovskyi V. (2025) Impact of the phagocytosis-stimulating effect of a new enterosorbent on the functional state of neutrophilic granulocytes. Health of Ukraine 21st Century, 18(604): 24–25.
23. Kolotilov S., Mishura A., Mazur D. (2026) Determination of the sorption capacity of the medical device «Alpesorb» with respect to 10 sorbates: potassium chloride (KCl), sodium chloride (NaCl), sodium citrate, glucose, vitamin B1, nicotinic acid (vitamin B3), folic acid (vitamin B9), acetaldehyde, acetone, ethanol (ethyl alcohol). Research report, State Registration No. 0126U002229. L.V. Pisarzhevsky Institute of Physical Chemistry, National Academy of Sciences of Ukraine, 19 p.